# STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study

> **NCT07269080** · PHASE1 · RECRUITING · sponsor: **University of Illinois at Chicago** · enrollment: 28 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Cancer

## Interventions

- **RADIATION:** Ablative radiation treatment

## Key facts

- **NCT ID:** NCT07269080
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-08
- **Primary completion:** 2028-01
- **Final completion:** 2028-11
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269080, "STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07269080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*